J

Vitamin D & Cancer/Cardiovascular Disease Prevention: How Effective Is It? Does It Prevent the Risk of Type 2 Diabetes?

By John Tayek 12 Videos
0 views
March 4, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Recommended

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
44:36
University of Colorado Cancer Center

Type 2 Diabetes Risk With Endocrine Therapies for Breast Cancer

Feat. R. Scalzo
27:02
The New York Course 2021 Virtual

Diabetes Management: How to Manage Diabetes in Persons Living With H…

Feat. T. Brown
32:34
Cardiometabolic Health Congress (CMHC)

Long-Term Cardiometabolic Risk in PCOS: How to Diagnose? Is Obesity …

Feat. A. Dokras-Jagasia
29:38
Practical Ways to Achieve Targets in Diabetes Care

COVID-19 Vaccine Recommendations for Diabetics and Diabetes Drug Saf…

Feat. S. Nissen, L. Yanoff, R. DeFronzo, G. Grunberger, S. Garg
18:59
Emory Diabetes Education Training Academy

Standards of Diabetes Care: Glycemic Targets and Pharmacological App…

Feat. G. Umpierrez
15:42
Emory Diabetes Education Training Academy

Monotherapy: A Comprehensive Comparison of Metformin, Sulfonylureas …

Feat. G. Umpierrez
06:48
Emory Diabetes Education Training Academy

Medication Management in Diabetes: How We Manage Diabetes Based on P…

Feat. G. Umpierrez
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez
11:06
Cardiometabolic Health Congress (CMHC)

ACC Guidelines on Diabetes, CVD & CKD: Will SGLT-2i Become a SoC…

Feat. S. Wiviott
25:29
Cardiometabolic Health Congress (CMHC)

47 y/o Male Referred for Evaluation of Obesity, Type 2 Diabetes &…

Feat. G. Bakris, S. Wiviott, R. Eckel
16:55
Cardiometabolic Health Congress (CMHC)

58 y/o Male Treated for Hypertension, Gout, Type 2 Diabetes, and Hyp…

Feat. G. Bakris, S. Wiviott, R. Eckel
09:19
Cardiometabolic Health Congress (CMHC)

Q&A on Cardiorenal Protection With SGLT-2 Inhibitors in T2DM and…

Feat. G. Bakris, S. Wiviott, R. Eckel
20:00
RheumNow

Rheumatic Diseases Update: What Is the Risk of Cardiovascular Events…

Feat. J. Cush
07:16
Stanford Medicine

Managing Diabetes During COVID-19: How to Do Motivational Interviewi…

Feat. E. Sheehan
26:03
Stanford Medicine

Nuts & Bolts of Remote Insulin Adjustment and Diabetes Education

Feat. E. Egan
15:40
John Tayek

2020 Updates on ADA Standard of Care: Managing Injectable Therapy an…

26:17
John Tayek

2020 Updates on Insulin Therapy: What Are the Current ADA Standards …

19:58
Naveed Sattar

What Do We Now Know About the Link Between Weight Gain, Diabetes and…

10:58
Naveed Sattar

Can Empagliflozin Successfully Treat T2D Whilst Preventing Heart Fai…